SCHEMBL2661902

SCHEMBL2661902

CC(C)C(=O)c1cc(C(=O)Nc2nccs2)n(Cc2ccc(F)c(C(F)(F)F)c2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.45
KMT2A Q03164 8/20 0.45
ALDH1A1 P00352 6/20 0.45
NPSR1 Q6W5P4 3/20 0.45
HPGD P15428 3/20 0.45
MAPK1 P28482 3/20 0.45
TSHR P16473 2/20 0.45
RECQL P46063 1/20 0.45
HSD17B10 Q99714 1/20 0.45
RXFP1 Q9HBX9 2/20 0.44
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
ADORA2A P29274 5/20 0.41
ADORA1 P30542 2/20 0.40
LMNA P02545 2/20 0.40
TP53 P04637 2/20 0.40
MAPT P10636 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ADORA2B P29275 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2662463 0.90 MEN1 (0.48) MEN1KMT2AALDH1A1NPSR1HPGD
SCHEMBL2662021 0.87 MEN1 (0.46) MEN1KMT2AALDH1A1NPSR1HPGD
SCHEMBL15104109 0.86 MEN1 (0.38) MEN1KMT2AALDH1A1NPSR1HPGD
SCHEMBL2661544 0.86 MEN1 (0.45) MEN1KMT2AALDH1A1NPSR1HPGD
SCHEMBL3756299 0.80 MEN1 (0.46) MEN1KMT2AALDH1A1NPSR1HPGD
SCHEMBL2662291 0.80 GCK (0.41) LMNATP53MAPT
SCHEMBL2661623 0.80 LMNA (0.42) LMNATP53MAPT
SCHEMBL27797247 0.79 LMNA (0.35) LMNATP53MAPT
SCHEMBL27797251 0.78 LMNA (0.36) LMNATP53MAPT
SCHEMBL2661981 0.78 MEN1 (0.46) MEN1KMT2AALDH1A1NPSR1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155720-B1 PYRROLE-2-CARBOXAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS PRIVATE LTD (IN) 2013-07-17 EP claimed
US-8299115-B2 Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2012-10-30 US claimed
US-20100292143-A1 PYRROLE-2-CARBOXAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2010-11-18 US claimed
EP-2155720-A1 PYRROLE-2-CARBOXAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION Advinus Therapeutics Private Limited (IN) 2010-02-24 EP claimed
WO-2008149382-A1 PYRROLE-2-CARBOXAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2008-12-11 WO claimed
EP-2155720-B1 PYRROLE-2-CARBOXAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS PRIVATE LTD (IN) 2013-07-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292143-A1 PYRROLE-2-CARBOXAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION GCK, PCK1, GCKR MEN1 4123/4885KMT2A 1673/4885ALDH1A1 1904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.